牛叉诊股

[{"date":"2026.03.30","stock":"5.13","trade":"1.18","ind":"-0.25"},{"date":"2026.03.27","stock":"3.13","trade":"2.53","ind":"1.13"},{"date":"2026.03.26","stock":"-0.84","trade":"-0.80","ind":"-1.41"},{"date":"2026.03.25","stock":"0.48","trade":"1.38","ind":"1.95"},{"date":"2026.03.24","stock":"5.04","trade":"3.44","ind":"1.43"},{"date":"2026.03.23","stock":"-7.03","trade":"-5.85","ind":"-3.76"},{"date":"2026.03.20","stock":"-2.40","trade":"-1.99","ind":"-0.25"},{"date":"2026.03.19","stock":"-2.23","trade":"-1.92","ind":"-2.02"},{"date":"2026.03.18","stock":"0.79","trade":"0.39","ind":"1.05"},{"date":"2026.03.17","stock":"-0.89","trade":"-0.68","ind":"-1.87"},{"date":"2026.03.16","stock":"1.01","trade":"0.40","ind":"0.19"},{"date":"2026.03.13","stock":"-1.00","trade":"-0.37","ind":"-0.65"},{"date":"2026.03.12","stock":"-0.22","trade":"-0.63","ind":"-0.63"},{"date":"2026.03.11","stock":"-1.86","trade":"-0.35","ind":"0.78"},{"date":"2026.03.10","stock":"2.69","trade":"1.42","ind":"2.04"},{"date":"2026.03.09","stock":"1.37","trade":"-0.27","ind":"-0.74"},{"date":"2026.03.06","stock":"2.33","trade":"1.93","ind":"0.59"},{"date":"2026.03.05","stock":"1.66","trade":"0.54","ind":"1.23"},{"date":"2026.03.04","stock":"-1.97","trade":"-1.09","ind":"-0.75"},{"date":"2026.03.03","stock":"-1.71","trade":"-1.58","ind":"-3.07"},{"date":"2026.03.02","stock":"-3.09","trade":"-2.12","ind":"-0.20"}]

佛慈制药,深证成指,中药指数

压力支撑

该股压力位为9.06元，支撑位为8.73元。

[{"text":"\u538b\u529b\u4f4d","value":"9.06","date":1774800000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"8.73","date":1774800000,"color":"0x0b52a1"}]

多空趋势

多头行情中，上涨趋势有所减缓，可适量做高抛低吸。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：3.1资金面打败了32%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

中药行业，近5日资金总体呈流入状态，投资者可考虑关注该行业的个股。

更新时间：03月31日 12:52

机构今日流向(万元)	697.07	机构5日流向(万元)	2729.05
机构10日流向(万元)	-2672.38	机构20日流向(万元)	-6268.77

机构持仓

2025-12-31 与 2025-06-30 相比，主力机构持仓量减少32480.74万股，其中基金数没有增加，主力净减仓7家，请投资者中长期谨慎为宜。

截止2025-12-31，共5家主力机构（基金5家），持仓量总计17.11万股，占流通A股0.03%
其中，基金持仓与2025-06-30相比：
增仓：0家，增持 0万股
减仓：0家，减持 0万股
新出现在主力名单中：5家，持有17.11万股
从主力名单中消失：12家，原持有32497.85万股

消息面诊股

诊断结果：5.5消息面打败了28%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	股东大会	临时股东大会	2026-03-25
一般消息	募资投向	公司购买资产	2026-03-10
一般消息	资产重组	公司股权转让	2026-03-07
一般消息	分红转增	不分配不转增	2025-08-27
一般消息	重大事项	关联交易	2025-05-23
一般消息	高管变动	取消监事会	2025-05-22
利好	分红转增	10派0.12元(含税)	2025-04-26

一年消息统计

	所有消息	重大消息	非重大消息
利好	1条	0条	1条
利空	0条	0条	0条

行业面诊股

诊断结果：6.5行业面打败了95%的股票中药行业最新资金流向

近10日来该行业走势不明显，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，接近大盘。

[{"date":"2026.03.30","price":"-0.25","value":"1.18"},{"date":"2026.03.27","price":"1.13","value":"2.53"},{"date":"2026.03.26","price":"-1.41","value":"-0.80"},{"date":"2026.03.25","price":"1.95","value":"1.38"},{"date":"2026.03.24","price":"1.43","value":"3.44"},{"date":"2026.03.23","price":"-3.76","value":"-5.85"},{"date":"2026.03.20","price":"-0.25","value":"-1.99"},{"date":"2026.03.19","price":"-2.02","value":"-1.92"},{"date":"2026.03.18","price":"1.05","value":"0.39"},{"date":"2026.03.17","price":"-1.87","value":"-0.68"},{"date":"2026.03.16","price":"0.19","value":"0.40"},{"date":"2026.03.13","price":"-0.65","value":"-0.37"},{"date":"2026.03.12","price":"-0.63","value":"-0.63"},{"date":"2026.03.11","price":"0.78","value":"-0.35"},{"date":"2026.03.10","price":"2.04","value":"1.42"},{"date":"2026.03.09","price":"-0.74","value":"-0.27"},{"date":"2026.03.06","price":"0.59","value":"1.93"},{"date":"2026.03.05","price":"1.23","value":"0.54"},{"date":"2026.03.04","price":"-0.75","value":"-1.09"},{"date":"2026.03.03","price":"-3.07","value":"-1.58"},{"date":"2026.03.02","price":"-0.20","value":"-2.12"}]

深证成指,中药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	万邦德	48.86%	52.58%	6.3分
2	嘉应制药	10.64%	12.86%	5.6分
3	九芝堂	6.91%	12.51%	5.8分
4	华润江中	6.56%	4.08%	6.7分
5	东阿阿胶	6.32%	4.70%	6.9分
6	健民集团	5.90%	3.83%	6.2分
7	天目药业	5.75%	16.60%	6.2分
8	振东制药	5.62%	11.71%	5.9分
9	康惠股份	4.81%	9.70%	5.9分
10	羚锐制药	4.34%	3.91%	6.8分
11	华神科技	3.48%	16.20%	5.8分
12	达仁堂	3.10%	7.19%	5.9分
13	众生药业	2.81%	11.54%	6.0分
14	佛慈制药	2.74%	13.48%	5.4分
15	桂林三金	2.71%	7.87%	6.0分
16	太龙药业	1.14%	11.97%	5.7分
17	古汉医药	1.01%	6.21%	6.1分
18	天士力	0.49%	6.21%	5.8分
19	亚宝药业	-0.15%	9.02%	6.6分
20	益盛药业	-0.61%	12.98%	5.4分
21	康恩贝	-0.67%	8.87%	6.2分
22	中恒集团	-0.78%	10.39%	5.6分
23	ST香雪	-0.95%	6.20%	5.5分
24	以岭药业	-1.00%	8.13%	6.3分
25	益佰制药	-1.01%	13.91%	4.9分
26	信邦制药	-1.20%	10.07%	5.5分
27	红日药业	-1.39%	9.57%	5.9分
28	金花股份	-1.70%	11.86%	5.9分
29	新天药业	-1.74%	13.53%	5.6分
30	新光药业	-1.83%	9.75%	5.4分
31	步长制药	-1.89%	8.01%	6.2分
32	康缘药业	-2.06%	3.14%	5.1分
33	云南白药	-2.25%	-0.35%	5.8分
34	华森制药	-2.56%	9.47%	4.6分
35	太极集团	-2.72%	10.44%	6.0分
36	华润三九	-2.98%	-1.63%	6.0分
37	仁和药业	-3.04%	7.49%	5.5分
38	广誉远	-3.04%	8.33%	5.3分
39	ST百灵	-3.24%	11.18%	5.2分
40	精华制药	-3.29%	8.41%	6.2分
41	特一药业	-3.29%	9.72%	6.4分
42	盘龙药业	-3.55%	8.39%	5.7分
43	陇神戎发	-3.59%	9.31%	5.7分
44	佐力药业	-3.78%	2.33%	5.8分
45	片仔癀	-4.39%	0.29%	5.1分
46	昆药集团	-4.48%	2.67%	5.1分
47	千金药业	-5.07%	7.45%	6.3分
48	汉森制药	-5.34%	10.87%	5.6分
49	济川药业	-5.36%	2.10%	5.8分
50	ST葫芦娃	-5.39%	6.21%	4.8分
51	马应龙	-5.40%	1.49%	5.2分
52	维康药业	-5.72%	11.09%	4.0分
53	沃华医药	-5.83%	8.21%	6.3分
54	恩威医药	-6.10%	8.27%	5.2分
55	三力制药	-6.19%	5.43%	5.6分
56	吉林敖东	-6.48%	3.77%	5.9分
57	同仁堂	-7.21%	-1.50%	5.2分
58	上海凯宝	-7.36%	5.34%	5.3分
59	康美药业	-7.37%	3.53%	5.8分
60	奇正藏药	-7.85%	5.09%	5.6分
61	葵花药业	-8.66%	5.55%	4.9分
62	珍宝岛	-8.70%	7.85%	5.3分
63	方盛制药	-9.11%	5.68%	5.4分
64	白云山	-9.33%	-0.30%	5.5分
65	寿仙谷	-10.28%	4.20%	5.0分
66	粤万年青	-11.54%	8.28%	4.2分
67	-	-12.37%	3.45%	分
68	-	-14.41%	2.39%	分
69	长药退	-59.09%	2.86%	4.0分

<上一页 1 2 3 4 5...12 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
中信证券	2012-09-10	增持	增持
招商证券	2012-09-08	增持	增持
航天证券	2012-09-06	增持	-
中银国际	2012-09-05	增持	-
齐鲁证券	2012-09-05	增持	-

基本面诊股

诊断结果：5.0基本面打败了17%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，暂时未获得多数机构的显著认同，后续可继续关注。

个股深一度

潜在高分红能力：弱（40分）

基本面得分最高的股票

[ 截止日期：2025-09-30 ]公司经营

盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 47/108 ， 56/108。

[{"date":"2025-09-30","value":"2.11","vol":"4.74"},{"date":"2025-06-30","value":"1.67","vol":"3.98"},{"date":"2025-03-31","value":"1.08","vol":"2.21"},{"date":"2024-12-31","value":"3.40","vol":"4.80"},{"date":"2024-09-30","value":"2.22","vol":"2.91"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净资产收益率(%)	2.11	1.67	1.08	3.40	2.22
行业(%)	4.74	3.98	2.21	4.80	2.91

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"32.92","vol":"52.48"},{"date":"2025-06-30","value":"33.87","vol":"53.04"},{"date":"2025-03-31","value":"34.28","vol":"53.56"},{"date":"2024-12-31","value":"30.58","vol":"52.79"},{"date":"2024-09-30","value":"32.02","vol":"53.11"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
销售毛利率(%)	32.92	33.87	34.28	30.58	32.02
行业(%)	52.48	53.04	53.56	52.79	53.11

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 44/108 ， 35/108。

[{"date":"2025-09-30","value":"-11.92","vol":"-7.63"},{"date":"2025-06-30","value":"-13.93","vol":"-7.68"},{"date":"2025-03-31","value":"-21.22","vol":"-7.53"},{"date":"2024-12-31","value":"-15.73","vol":"-7.39"},{"date":"2024-09-30","value":"-19.75","vol":"-5.11"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
营业收入同比增长率(%)	-11.92	-13.93	-21.22	-15.73	-19.75
行业(%)	-7.63	-7.68	-7.53	-7.39	-5.11

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"-2.54","vol":"-2.70"},{"date":"2025-06-30","value":"-16.60","vol":"2.90"},{"date":"2025-03-31","value":"5.41","vol":"-37.21"},{"date":"2024-12-31","value":"-10.60","vol":"-146.29"},{"date":"2024-09-30","value":"-34.97","vol":"61.78"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净利润同比增长率(%)	-2.54	-16.60	5.41	-10.60	-34.97
行业(%)	-2.70	2.90	-37.21	-146.29	61.78

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 48/108 ， 44/108。

[{"date":"2025-09-30","value":"0.25","vol":"0.35"},{"date":"2025-06-30","value":"0.17","vol":"0.24"},{"date":"2025-03-31","value":"0.09","vol":"0.12"},{"date":"2024-12-31","value":"0.39","vol":"0.50"},{"date":"2024-09-30","value":"0.28","vol":"0.37"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
总资产周转率(次)	0.25	0.17	0.09	0.39	0.28
行业(次)	0.35	0.24	0.12	0.50	0.37

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"1.24","vol":"1.72"},{"date":"2025-06-30","value":"0.82","vol":"1.18"},{"date":"2025-03-31","value":"0.43","vol":"0.60"},{"date":"2024-12-31","value":"1.92","vol":"2.41"},{"date":"2024-09-30","value":"1.24","vol":"1.81"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
存货增长率(次)	1.24	0.82	0.43	1.92	1.24
行业(次)	1.72	1.18	0.60	2.41	1.81

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2025-09-30","value":"38.84","vol":"9.43"},{"date":"2025-06-30","value":"4.58","vol":"20.06"},{"date":"2025-03-31","value":"3.75","vol":"-0.30"},{"date":"2024-12-31","value":"20.30","vol":"15.76"},{"date":"2024-09-30","value":"-4.49","vol":"5.86"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
现金流量净额/营业收入	38.84	4.58	3.75	20.30	-4.49
行业	9.43	20.06	-0.30	15.76	5.86

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.36","vol":"1.02"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.24","vol":"1.45"},{"date":"2024-09-30","value":"","vol":"0.00"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资本支出／折旧和摊销	-	0.36	-	0.24	-
行业	0.00	1.02	0.00	1.45	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 34/108 ， 45/108。

[{"date":"2025-09-30","value":"3.10","vol":"3.05"},{"date":"2025-06-30","value":"3.20","vol":"2.90"},{"date":"2025-03-31","value":"3.63","vol":"2.99"},{"date":"2024-12-31","value":"3.22","vol":"2.88"},{"date":"2024-09-30","value":"3.00","vol":"3.25"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
流动比率	3.10	3.20	3.63	3.22	3.00
行业	3.05	2.90	2.99	2.88	3.25

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"2.21","vol":"2.21"},{"date":"2025-06-30","value":"2.19","vol":"2.13"},{"date":"2025-03-31","value":"2.55","vol":"2.22"},{"date":"2024-12-31","value":"2.22","vol":"2.11"},{"date":"2024-09-30","value":"1.90","vol":"2.43"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
速动比率	2.21	2.19	2.55	2.22	1.90
行业	2.21	2.13	2.22	2.11	2.43

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 33/108 ， 37/108。

[{"date":"2025-09-30","value":"26.86","vol":"33.12"},{"date":"2025-06-30","value":"26.16","vol":"33.87"},{"date":"2025-03-31","value":"24.19","vol":"33.29"},{"date":"2024-12-31","value":"26.51","vol":"34.05"},{"date":"2024-09-30","value":"27.42","vol":"32.87"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资产负债率(%)	26.86	26.16	24.19	26.51	27.42
行业(%)	33.12	33.87	33.29	34.05	32.87

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.37","vol":"0.75"},{"date":"2025-06-30","value":"0.36","vol":"0.74"},{"date":"2025-03-31","value":"0.32","vol":"0.72"},{"date":"2024-12-31","value":"0.37","vol":"0.75"},{"date":"2024-09-30","value":"0.38","vol":"3.20"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
产权比率 (%)	0.37	0.36	0.32	0.37	0.38
行业(%)	0.75	0.74	0.72	0.75	3.20

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构对该股票关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无数据

机构预测

暂时还没有机构预测该股2025年的收益，请投资者后续关注。

[{"date":"2021","yellowRectValue":"0.93","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"1.06","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.67","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.60","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]

[佛慈制药]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]